Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Pamon Steve	2. Issuer Name and Ticker or Trading Symbol IMAX CORP [ IMAX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O IMAX CORPORATION, 902 BROADWAY, 20TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 6/10/2021
(Street) NEW YORK, NY 10010-6002 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								0	D
common shares	6/10/2021		M		5585 (1)	A	$0.00 (2)	5585	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
restricted share units (3)	$0.00 (2)	6/10/2021		A		5585 (4)		(5)	(5)	common shares	5585	(4)	5585	D
restricted share units (3)	$0.00 (2)	6/10/2021		M			5585 (1)	(5)	(5)	common shares	5585	(6)	0	D

Explanation of Responses:
(1)	Represents the conversion upon vesting of restricted share units into common shares.
(2)	Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
(3)	Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
(4)	Mr. Pamon received a grant of restricted share units in connection with his membership on the IMAX Corporation Board of Directors.
(5)	The restricted share units vest and convert to common shares on the date of grant, June 10, 2021.
(6)	Pursuant to Instruction 4(C)(iii), this response has been left blank.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Pamon Steve C/O IMAX CORPORATION 902 BROADWAY, 20TH FLOOR NEW YORK, NY 10010-6002	X

Signatures
/s/ Steve Pamon		6/10/2021
**Signature of Reporting Person		Date